Cell-based neoantigen vaccines and uses thereof Grant US-11723962-B2 United States of America 15 Aug 2023
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS Application EP-3871691-A1 European Patent Office 01 Sep 2021
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES Application EP-3848030-A1 European Patent Office 14 Jul 2021
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES Application EP-3760201-A1 European Patent Office 06 Jan 2021
CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS Application EP-3682878-A1 European Patent Office 22 Jul 2020
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS Application EP-3679933-A1 European Patent Office 15 Jul 2020
SYNTHETIC NANOCARRIERS THAT GENERATE HUMORAL AND CYTOTOXIC T LYMPHOCYTE (CTL) IMMUNE… Application WO-2013019669-A2 World Intellectual Property Organisation (WIPO) 07 Feb 2013
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS Application WO-2012149393-A2 World Intellectual Property Organisation (WIPO) 01 Nov 2012
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+REGULATORY T CELLS Application WO-2012149282-A2 World Intellectual Property Organisation (WIPO) 01 Nov 2012
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES Application WO-2012149259-A1 World Intellectual Property Organisation (WIPO) 01 Nov 2012
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY Application WO-2012149268-A1 World Intellectual Property Organisation (WIPO) 01 Nov 2012
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR INDUCING REGULATORY B CELLS Application WO-2012149301-A2 World Intellectual Property Organisation (WIPO) 01 Nov 2012